- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Pseudobulbar Affect (PBA) In Patients With Traumatic Brain Injury (TBI)

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Pseudobulbar Affect (PBA) In Patients With Traumatic Brain Injury (TBI)
Join us as Michelle Lavagnino and Dr. Heidi Fusco discuss an overview of Pseudobulbar Affect (PBA) in Traumatic Brain Injury (TBI) patients. This webinar will discuss the prevalence and burden of TBI patients suffering from PBA and the importance of diagnosing in several different practice settings.

Heidi Fusco, PM&R
Assistant Professor, Department of Rehabilitation Medicine at NYU Grossman School of Medicine; Medical Director, Brain Injury Unit, Queens Nassau Nursing and Rehabilitation; Assistant Director, Traumatic Brain Injury Program

Michelle Lavagnino, DrPH(c)
Medical Science Liaison, Long-term Care
Dr. Heidi Fusco is a paid consultant of Otsuka Pharmaceutical Development & Commercialization. (OPDC)
Michelle Lavagnino is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)